Status:
COMPLETED
Cf-DNA Assay During Treatment of Acute Rejection
Lead Sponsor:
University of Minnesota
Conditions:
Kidney Transplant Failure and Rejection
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to determine whether cell-free DNA (cf-DNA) measurement can be used as a biomarker for successful treatment of an acute rejection (AR) episode after kidney transplantati...
Detailed Description
Significance of Research Question/Purpose: A kidney transplant biopsy is the gold standard for making a diagnosis at the time of graft dysfunction. However, there are risks associated with a transpla...
Eligibility Criteria
Inclusion
- Adult kidney transplant recipients undergoing transplant biopsy between 1 and 12 months post-transplant because of graft dysfunction.
Exclusion
- \<1 months post-transplant
- \>12 months post-transplant
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 5 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04019353
Start Date
June 1 2019
End Date
September 5 2023
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455